‘Viagra for women’ may be available in 2016

In just three years’ time, it could be that men are not the only sex who get a helping hand in the bedroom, as Dutch scientists are developing two new drugs to cure the loss of a woman’s desire, one of which is a testosterone-based therapy to heighten pleasure.

The revolutionary new drugs Lybrido and Lybridos, or ‘Female Viagra’ as they are being nicknamed, are being developed by Dutch and US firm Emotional Brain, who claim either could be on bedside cabinets across the world by 2016, being used to boost a woman’s sexual desire and increase feelings of satisfaction in the bedroom.

Currently, men hugely benefit through medicines such as Viagra, Cialis or Levitra for impotence, in addition to Priligy and Stud 100 spray for premature ejaculation. Women’s bedroom issues are often overlooked and ignored, but not for much longer!

The creators Emotional Brain were founded in 2001 primarily to pioneer innovative health care. A lot of their work is targeted at researching women’s sexual health. The twelve years following, many experts have tried to find causes for Female Sexual Dysfunction (FSD) and targeted therapy to treat the problem.

Unfortunately, previous treatments have been found relatively ineffective as female libido is commonly linked to psychological issues and not merely physical factors.

Emotional Brain believes they may have created something to beat the problem through two-in-one pills that will target both the body and brain.

The pills will be sized smaller than a typical aspirin and Lybrido will be comprised of a Viagra-like drug coated in a testosterone and will have a minty taste. Both components may be weak to combat low libido separately, but the testosterone-coating that melts in the mouth followed by a delayed-release of the Viagra-type substance.

Lyrbridos however will have its Viagra-like molecule replaced buspirone; an anti-anxiety medication that increases levels of the hormone serotonin. Unlike Viagra, Lybridos targets brain areas associated with sexual desire, encouraging the brain to realign with intimacy.

U.S. trials have finished involving more than 200 women have recently been completed, and Emotional Brain founder Adriaan Tuiten states the results from both drugs are ‘very, very promising’.
Dr Tuiten was prompted to research into female emotions after having his heart broken by an ex-girlfriend whilst he was in his 20s. It is his belief that the treatments will be a massive hit especially amongst women who have been married for many years and for whom sex may have lost the appeal and become stale over time.

Dr Tuiten says up to 43% of women experience a low sex drive at some point in their lives and has alleviated fears that the new drugs wills turn women into sex-crazed nymphomaniacs, stating that the treatments will work at simply increasing low-libido to more ‘normal’ levels.